In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work.
A riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.
RSVP for our Books on Tap discussion of John Carreyrou's “Bad Blood.” Don't forget to stop by the library to borrow a copy of the book. We'll get settled, order food/drinks, and catch up with everyone at 7pm on Tuesday, December 18 at The Sitting Duck Tavern. Our book discussion starts at 7:30pm. Cheers!